4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-8-trifluoromethyl-naphthalene-2-carboxylic acid

ID: ALA157426

PubChem CID: 10811936

Max Phase: Preclinical

Molecular Formula: C20H17F3N4O3

Molecular Weight: 418.38

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1cc(CCn2cnc3c2NC=NCC3O)c2cccc(C(F)(F)F)c2c1

Standard InChI:  InChI=1S/C20H17F3N4O3/c21-20(22,23)15-3-1-2-13-11(6-12(19(29)30)7-14(13)15)4-5-27-10-26-17-16(28)8-24-9-25-18(17)27/h1-3,6-7,9-10,16,28H,4-5,8H2,(H,24,25)(H,29,30)

Standard InChI Key:  UXTGUAXZRZHQJJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.2125   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6500   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4500   -1.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1750   -1.9417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2542   -3.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6042   -2.8375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7667   -4.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0500   -1.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2542   -3.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7875   -2.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7875   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7417   -2.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7417   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3125   -1.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6167   -1.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1167   -3.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5292   -3.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6917   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2250   -1.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3250   -1.3625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2500   -4.3500    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8750   -4.6875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.3625   -3.8417    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.8375   -2.2667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2750   -1.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3250   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7292   -4.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2125   -3.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2125   -3.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  2  1  0
  5 12  1  0
  6  2  1  0
  7  9  1  0
  8  3  2  0
  9  5  1  0
 10 11  1  0
 11 16  2  0
 12 13  2  0
 13 20  1  0
 14 11  1  0
 15  1  1  0
 16 13  1  0
 17  6  1  0
 18 27  1  0
 19  4  1  0
 20 19  1  0
 21 14  2  0
 22  7  1  0
 23  7  1  0
 24  7  1  0
 25 14  1  0
 26 15  1  0
 27 15  1  0
 28 30  1  0
 29 12  1  0
 30 29  2  0
  8  4  1  0
 17 18  2  0
 10  5  2  0
  9 28  2  0
M  END

Associated Targets(Human)

AMPD3 Tchem AMP deaminase 3 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 418.38Molecular Weight (Monoisotopic): 418.1253AlogP: 3.48#Rotatable Bonds: 4
Polar Surface Area: 99.74Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.96CX Basic pKa: 6.50CX LogP: 0.91CX LogD: 0.20
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.60Np Likeness Score: -0.33

References

1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD..  (2001)  AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.,  44  (4): [PMID:11170651] [10.1021/jm000355t]

Source